Inficon reported preliminary FY 2025 sales of $673.7 million, roughly flat year-over-year but 1% above consensus. Operating income hit $112.3 million, implying a 16.7% EBIT margin that outperformed forecasts by about 2%. The key takeaway was a sharp Q4 margin rebound, with an estimated 17.5% EBIT margin representing a 350 basis point recovery from the prior quarter.

The margin improvement came as one-off costs from reconfiguring its global production footprint began to fade. Analyst Craig Abbott of Kepler Cheuvreux called the delivery encouraging after a year pressured by tariffs, currency volatility, and soft wafer fab equipment capex. Despite the positive surprise, shares slid 2% in European trading, suggesting recent price strength tempered the reaction.

Investors now await full results and initial 2026 guidance on March 24 for clarity on order intake and the sustainability of the margin recovery. The company operates in a challenging sector, and the market will be looking for evidence that the Q4 performance marks a turning point rather than a temporary rebound from a volatile operating backdrop.